Aptamer-functionalized nanoparticles for medical applications: challenges and opportunities.
about
Nanomedicine therapeutic approaches to overcome cancer drug resistanceTargeted therapy using nanotechnology: focus on cancerNANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?Comparison of the 'chemical' and 'structural' approaches to the optimization of the thrombin-binding aptamerNanotechnology in the war against cancer: new arms against an old enemy - a clinical view.Synthetic aptamer-polymer hybrid constructs for programmed drug delivery into specific target cellsMultifunctional nanocarriers for simultaneous encapsulation of hydrophobic and hydrophilic drugs in cancer treatment.Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.Detection and characterization of cancer cells and pathogenic bacteria using aptamer-based nano-conjugatesNucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicineAptamers: active targeting ligands for cancer diagnosis and therapyAptamer technology for tracking cells' status & function.Reductively degradable α-amino acid-based poly(ester amide)-graft-galactose copolymers: facile synthesis, self-assembly, and hepatoma-targeting doxorubicin delivery.Characterization of DNA aptamers generated against the soft-shelled turtle iridovirus with antiviral effects.Self-assembled hybrid nanoparticles for targeted co-delivery of two drugs into cancer cellsRecent advances in biocompatible nanocarriers for delivery of chemotherapeutic cargoes towards cancer therapy.Current advances in lanthanide ion (Ln(3+))-based upconversion nanomaterials for drug delivery.Aptamers as drug delivery vehicles.Micro- and nanotechnologies for intracellular delivery.Vectors for the delivery of radiopharmaceuticals in cancer therapeutics.The Effects of Spacer Length and Composition on Aptamer-Mediated Cell-Specific Targeting with Nanoscale PEGylated Liposomal Doxorubicin.Targeting cancer cells with controlled release nanocapsules based on a single aptamer.Aptamers and their applications in nanomedicine.Aptamer-Functionalized Nanoparticles as "Smart Bombs": The Unrealized Potential for Personalized Medicine and Targeted Cancer Treatment.808-nm-Light-Excited Lanthanide-Doped Nanoparticles: Rational Design, Luminescence Control and Theranostic Applications.Liposomal drug delivery systems for targeted cancer therapy: is active targeting the best choice?Modular Assembly of Cell-targeting Devices Based on an Uncommon G-quadruplex Aptamer.Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy.Nanolayered siRNA dressing for sustained localized knockdown.Statins anticancer targeted delivery systems: re-purposing an old molecule.Development and characterization of aptamer-based enzyme-linked apta-sorbent assay for the detection of Singapore grouper iridovirus infection.Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction.Materiomics for Oral Disease Diagnostics and Personal Health Monitoring: Designer Biomaterials for the Next Generation Biomarkers.Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications.Metal-enhanced fluorescent detection for protein microarrays based on a silver plasmonic substrate.AS1411 aptamer-conjugated Gd2O3:Eu nanoparticles for target-specific computed tomography/magnetic resonance/fluorescence molecular imaging
P2860
Q27011692-798D1BC0-F99E-42F7-ACAC-B6319F6E102BQ27023361-60199859-12B5-45B8-9AC0-B3962802226EQ28078448-27AA8F45-4397-494F-B47E-D5E7B9186E2DQ28540023-A0E4111C-1A42-44D2-80AC-5AA7AA7E5C8BQ30376531-76D780EB-9E38-4470-B4A5-093E73931A7EQ34408096-70EEF8FB-51FA-46C9-8143-0D6EFBA798C0Q34440323-D490F667-294F-47D7-99B6-B60EA8976F74Q34447986-CF1ECD58-D9BB-475B-ABC7-DC97C4241C52Q34554135-16820422-7890-4EEB-933F-56D80F27A660Q34698624-63C7E593-60CD-4306-A611-5F900E42C95DQ35086493-924863A2-07A0-41C3-880B-87F1417C0231Q35673895-4937AD14-7BF8-4C3C-BC32-6DEA52537F67Q35722420-4D5A4E76-D69D-421E-934E-5311932C2546Q35792236-96F46ECC-BC3F-4198-A010-726031DC7221Q37679875-C857B569-E73C-464F-88C7-89981E3F9620Q38204933-8CC09C09-5D8B-4EB8-8AE0-237A59A1959EQ38225630-35083A30-2ADD-4A1A-9057-E2B3223ED672Q38240594-EBE93908-8AFA-486B-BA13-D43E9327AF9DQ38244304-BE45A0D8-202B-4075-B2DE-FA61F9407AA1Q38261959-AC248CD3-A5C5-46DC-BA27-2FE0AA0F8116Q38292678-0CF5D345-BD6D-4A7E-AA74-FD37F6ED5A11Q38318762-2DB80E46-2A19-4008-B936-6D04A63F95BFQ38353973-3DA617FB-9393-438C-A658-3163A224A8CCQ38491805-8BE21182-A2F1-46BE-874D-981EF6F24139Q38744965-69CA3653-7E7B-49A5-B783-DAAA8CCD4FDAQ38806793-723E8BFB-F298-4EB7-B9B9-78E71D920AB6Q38968703-6E5C52B7-3A37-4C66-8577-87988561535CQ38976861-89EFC678-E196-4654-893C-8E5ABD6F25CCQ39152253-1F5D2887-D99B-46BC-8FE3-ED9C801EE132Q39167606-63EADD5E-C616-4DA1-B94A-486930C45795Q39176247-D35AE5BF-C815-480F-AB3E-C210EB55914AQ41018640-4F6CF403-3044-4147-ABE8-975A71D632CFQ41828336-555C6FAA-979F-4ACA-9197-4B558110473FQ47589446-29A86518-C280-4838-9CF5-38C6DDF91A75Q53624818-C7D69D97-F192-4379-A114-DDFFC036A600Q57353070-68F87805-E62D-4D0B-A5CE-7C4E96B3A491
P2860
Aptamer-functionalized nanoparticles for medical applications: challenges and opportunities.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Aptamer-functionalized nanopar ...... challenges and opportunities.
@ast
Aptamer-functionalized nanopar ...... challenges and opportunities.
@en
type
label
Aptamer-functionalized nanopar ...... challenges and opportunities.
@ast
Aptamer-functionalized nanopar ...... challenges and opportunities.
@en
prefLabel
Aptamer-functionalized nanopar ...... challenges and opportunities.
@ast
Aptamer-functionalized nanopar ...... challenges and opportunities.
@en
P2860
P356
P1433
P1476
Aptamer-functionalized nanopar ...... : challenges and opportunities
@en
P2093
Omid C Farokhzad
P2860
P304
P356
10.1021/NN301869Z
P407
P577
2012-05-10T00:00:00Z